Intra-hospital mortality and morbidity and six-month follow up of patients with myocardial infarction


  • Behzad Babapour Department of Internal Medicine, Ardabil University of Medical Science, Ardabil, Iran
  • Saeid Sadeghieh-Ahari Department of Community Medicine, Ardabil University of Medical Science, Ardabil, Iran
  • Saba Panahi School of Medicine, Ardabil University of Medical Science, Ardabil, Iran



Mortality, Morbidity, Acute myocardial infarction


Background: Cardiovascular disease is one of the leading causes of disability and premature death worldwide. Adjustment of risk factors has been shown to reduce morbidity and mortality in people with diagnosed or even undiagnosed cardiovascular disease. In this study, we examined mortality and morbidity over a six-month period among patients with MI.

Methods: This cross-sectional study was done on 322 patients admitted to Imam Khomeini Hospital in Ardabil during September 2020 to February 2020 with the diagnosis of acute myocardial infarction and their mortality and morbidity rates and their relationship with age, gender, risk factors (diabetes, hypertension, family history) and the type of treatment performed. The data of all patients will be collected in special forms and will be analyzed using SPSS software.

Results: Of all patients, 27 died, all of whom were older (over 59 years), and about 125 had morbidity during 6 months, the majority (78%) being older. In terms of gender, mortality and morbidity rates were lower in men than in women. Risk factors lie diabetes, hypertension and positive family history had a significant impact on mortality and morbidity at first glance and findings showed that streptokinase injection was superior to primary coronary intervention with mortality and morbidity.

Conclusions: Findings showed that mortality and morbidity rate in acute myocardial infarction was directly related to the type of treatment (primary coronary intervention versus streptokinase injection), age, sex, being diabetic, having hypertension and having a positive family history.


Rai A, Karim H, Salehi N, Saidi M, Bahremand M, Kazerani H. Comparison of in hospital morbidity and mortality and 6-month outcome between primary percutaneous coronary intervention and streptokinase injection in Imam Ali and Bistoon Hospitals, Kermanshah in 2015. Tech J Eng App Sci. 2016;3:1-6.

Andrés E, Cordero A, Magán P, Alegría E, León M, Luengo E, et al. Long-term mortality and hospital readmission after acute myocardial infarction: an eight-year follow-up study. Rev Esp Cardiol. 2012;65(5):414-20.

Beyranvard M, Lorvand A, Alipuor S, Motamedi M, Kolahi A. Quality of life after acute myocardial infarction: a systematic review. Can J Cardiol. 2003; 19(5):507-11.

Simpson C, Buckley B, Mclernon D, Sheikh A, Murphy A. Five-Year Prognosis in an Incident Cohort of People Presenting with Acute Myocardial Infarction. PLoS ONE. 2011;42:1-7.

Johansson S, Rosengren A, Young K, Jennings E. Mortality and morbidity trends after the first year in survivors of acute myocardial infarction. BMC Cardiovasc Disord. 2017;4:1-8.

Wilson P, Douglas P, Simons M, Alpert J. Prognosis after myocardial infarction. N Engl J Med. 2017;4:339-61.

Chung SH, Gedeborg R, Nicholas O, Jeppsson A. Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK. N Engl J Med. 2014;13:1305-12.

Smolina K, Wright L, Rayner M, Goldacre M. Long-term survival and recurrence after acute myocardial infarction in England, 2004 to 2010. Circ Cardiovasc Qual Outcomes J. 2014;3:532-40.

Noohi F, Hashemi I, Sanati H, Peighambari M, Kiavar M, Madani M. In-hospital and six-month outcomes of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. Atheroscler. 2016;45:28-34.

Khosravai A, Ebrahini H. Evaluation of one-year survival probability and its effective factors in myocardial infarction patients. J Shahroud Med Sci. 2008;3:1-7.

Kishpaugh K, Ford M, Castle H, Reading J. Myocardial infarction: a five-year follow-up of patients. West J Med. 2014;134:1-6.

Amani F, Hajizadeh E, Hoseinian F. Survival rate in MI patients. Koomesh. 2008;9(2):131-8.

Kiani F, Hesabi N, Arbabisarjou A. Assessment of risk factors in patients with myocardial infarction. Global J Health Sci. 2015;34:255-62.

Hashemi SM, Firouzfar A, Hajheidari P, Yadegarfar G, Danesh M, Shoureshi P. Anatomic distribution of coronary culprit lesion and five-year follow-up for major adverse cardiac events (MACE) in patients with acute coronary syndrome. J Isfahan Med Sci. 2017;35:1074-9.

Salehi E, Hagizadeh E, Alidoosti M. Evaluation risk factors of coronary artery disease through competing risk tree. J Arak Uni Med Sci. 2018;21(4):18-29.

Jonas M, Reiss1 H, Boyko V. Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension. J Human Hypertens. 2011;4:665-70.

Gustafsson F, Køber L, Pedersen C, Hildebrandt P. Long-term prognosis after acute myocardial infarction in patients with a history of arterial hypertension. Eur Heart J. 1998;23:588-94.

Salarifar M, Kazemeini SM, Haji ZAM. Prevalence of Coronary Artery Disease and related risk factors in first degree relatives of patients with premature CAD Tehran Heart Center. Tehran Univ Med J. 2008;65(1):49-54.




How to Cite

Babapour, B., Sadeghieh-Ahari, S., & Panahi, S. (2022). Intra-hospital mortality and morbidity and six-month follow up of patients with myocardial infarction. International Journal of Research in Medical Sciences, 10(11), 2348–2352.



Original Research Articles